Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Finance Today.
Press releases published on June 24, 2025
Alpine IQ Acquires Happy Cabbage’s Marketing Suite “Happy Marketers,” Expanding Value for Retail Clients
GlobeNewswire
·
June 24, 2025
DENVER, June 24, 2025 (GLOBE NEWSWIRE) -- Alpine IQ, the industry leader in data management, telecom, and marketing solutions for cannabis retailers, and the second fastest-growing software company on the 2024 Inc. 5000 software list, proudly announces its …
Hapbee Delivers Breakout Q1 2025: Record Growth, Leaner Operations, and a Clear Path to Scalable Profitability
GlobeNewswire
·
June 24, 2025
VANCOUVER, British Columbia, June 24, 2025 (GLOBE NEWSWIRE) -- Hapbee Technologies Inc. (TSXV: HAPB | OTCQB: HAPBF), (“Hapbee” or the “Company”), the digital wellness technology company pioneering the science of bio-streaming, announced today its …
Novo Announces AGM Results
GlobeNewswire
·
June 24, 2025
PERTH, Western Australia, June 24, 2025 (GLOBE NEWSWIRE) -- Novo Resources Corp. (Novo or the Company) (ASX: NVO) (TSX: NVO) (OTCQX: NSRPF) reports that all resolutions proposed to shareholders at the annual general meeting of shareholders (held on June 23 …
Concord Crest Real Estate Announces the Launch of Its Operations in Miami
GlobeNewswire
·
June 24, 2025
MIAMI, FL, June 24, 2025 (GLOBE NEWSWIRE) -- Concord Crest Real Estate (“CCRE”), a partnership between Crest Real Estate (“Crest”) and Concord Wilshire Companies (“CW”), announces the launch of its operations in Miami. The new company facilitates the …
Texas Builders See Solid Late Spring Surge
GlobeNewswire
·
June 24, 2025
DALLAS, June 24, 2025 (GLOBE NEWSWIRE) -- Texas home builders experienced a solid late spring surge as new home sales in May reached their highest level so far this year, according to the latest Texas New Home Sales Report released today by HomesUSA.com …
Cosmos Health Enters U.S. Market with Strategic Made-in-America Manufacturing, Mitigating Tariff Risks; Executes Agreement with New Jersey-Based DolCas Biotech
GlobeNewswire
·
June 24, 2025
CHICAGO, June 24, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R…
Bitget Lists Humanity Protocol (H) for Spot Trading
Chainwire
·
June 24, 2025
Victoria, Seychelles, June 24th, 2025, Chainwire Bitget, the leading cryptocurrency exchange and Web3 company, has announced the listing of Humanity (H), adding it to spot trading. Humanity Protocol is an emerging anti-Sybil blockchain network designed to …
Byreal Signals Dawn of Onchain Capital Markets with Bold Debut at Solana APEX
Chainwire
·
June 24, 2025
BUDAPEST, Hungary, June 24th, 2025, Chainwire At one of the most anticipated fireside sessions of Solana APEX, three industry heavyweights—Solana Foundation President Lily Liu, Bybit Co-founder and CEO Ben Zhou, and Byreal Founder Emily Bao—came together …
CBE Companies Receives 2025 BBB Torch Award for Ethics
GlobeNewswire
·
June 24, 2025
CEDAR FALLS, Iowa, June 24, 2025 (GLOBE NEWSWIRE) -- CBE Companies is honored to be named a 2025 Torch Awards for Ethics recipient by the Better Business Bureau, recognizing its commitment to ethical leadership, transparency, and long-term trust-building …
No KYC. 100x Leverage. Double Deposit Bonus. Crypto Futures Trading Made Easy on BexBack.
GlobeNewswire
·
June 24, 2025
SINGAPORE , June 24, 2025 (GLOBE NEWSWIRE) -- With the price of Bitcoin fluctuating around $100,000, many analysts predict that the cryptocurrency market will remain in a state of high volatility for a long time. Holding spot positions may struggle to …
Fortrea und Emery Pharma kündigen strategische Zusammenarbeit zur Durchführung FDA-konformer Arzneimittelwechselwirkungsstudien mit Rifampin an
GlobeNewswire
·
June 24, 2025
Durham, North Carolina, June 24, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (das „Unternehmen“), ein führendes globales Auftragsforschungsinstitut (Contract Research Organization CRO), hat heute eine strategische Zusammenarbeit mit Emery Pharma …
Fortrea et Emery Pharma annoncent une collaboration stratégique visant à mener des études sur les interactions médicamenteuses répondant aux normes de la FDA en utilisant la rifampicine
GlobeNewswire
·
June 24, 2025
DURHAM, Caroline du Nord, 24 juin 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq : FTRE) (la « Société »), une société de recherche contractuelle d’envergure mondiale (CRO) de premier plan, a annoncé aujourd’hui une collaboration stratégique avec Emery Pharma, …
Fortrea & Emery Pharma Umumkan Kolaborasi Strategis untuk Melakukan Studi Interaksi Obat-Obat yang Sesuai Peraturan FDA dengan Menggunakan Rifampin
GlobeNewswire
·
June 24, 2025
DURHAM, N.C., June 24, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (“Perusahaan”), perusahaan riset berbasis kontrak (CRO) global terkemuka, hari ini mengumumkan kolaborasi strategis dengan Emery Pharma, CRO analitik dan bioanalitik terkemuka yang …
Fortrea y Emery Pharma anuncian colaboración estratégica para realizar estudios de interacción fármaco-fármaco que cumplan con la FDA utilizando rifampicina
GlobeNewswire
·
June 24, 2025
DURHAM, Carolina del Norte, June 24, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (la "Empresa"), una organización líder mundial en investigación por contrato (CRO), anunció hoy una colaboración estratégica con Emery Pharma, una CRO analítica y …
Fortrea ו-Emery Pharma מכריזות על שיתוף פעולה אסטרטגי לביצוע מחקרי אינטראקציה בין תרופות באמצעות ריפמפיצין, בהתאם לתקני ה-FDA
GlobeNewswire
·
June 24, 2025
דורהאם, קרוליינה הצפונית, June 24, 2025 (GLOBE NEWSWIRE) -- Fortrea (נאסד"ק:FTRE) ("החברה"), חברה שהיא ארגון מחקר מבוסס חוזים (CRO) גלובלית מובילה, הודיעה היום על שיתוף פעולה אסטרטגי עם Emery Pharma, חברת CRO אנליטית וביו-אנליטית מובילה המספקת שירותי בדיקה …
Fortrea dan Emery Pharma Umumkan Kerjasama Strategik untuk Menjalankan Kajian Interaksi Ubat yang Mematuhi Piawaian FDA Menggunakan Rifampin
GlobeNewswire
·
June 24, 2025
DURHAM, N.C., June 24, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (“Syarikat”), sebuah organisasi penyelidikan kontrak (CRO) global terkemuka, hari ini mengumumkan kerjasama strategik dengan Emery Pharma, sebuah CRO analitik dan bioanalitik terkemuka …
Fortrea & Emery Pharma Anunciam Colaboração Estratégica para Fornecer Estudos de Interação Medicamentosa Usando Rifampicina em Conformidade com o FDA
GlobeNewswire
·
June 24, 2025
DURHAM, N.C., June 24, 2025 (GLOBE NEWSWIRE) -- A Fortrea (Nasdaq: FTRE) (a “Empresa”), uma organização líder global de pesquisa por contrato (CRO), anunciou hoje uma colaboração estratégica com a Emery Pharma, uma CRO analítica e bioanalítica líder que …
フォートリア (Fortrea) とエメリー・ファーマ (Emery Pharma)、リファンピンを用いたFDA準拠の薬物相互作用 (Drug-Drug-Interaction、DDI) 試験を提供するための戦略的提携を発表
GlobeNewswire
·
June 24, 2025
ノースカロライナ州ダーラム発, June 24, 2025 (GLOBE NEWSWIRE) -- グローバルな大手医薬品開発業務受託機関 (CRO) であるフォートリア (NASDAQ: FTRE)(以下「同社」) は本日、大手分析・バイオ分析CROとしてcGMPおよびGLPに準拠した試験サービスを提供するエメリー・ファーマとの戦略的提携を発表した。この提携により、薬物相互作用 (DDI) 試験で使用される主要薬剤であるリファンピンに対し、1-メチル-4-ニトロソピペラジン (MNP) …
Fortrea 與 Emery Pharma 宣佈開展戰略合作，使用利福平 (Rifampin) 開展符合 FDA 要求的藥物相互作用試驗
GlobeNewswire
·
June 24, 2025
達勒姆，北卡羅來納州, June 24, 2025 (GLOBE NEWSWIRE) -- 全球領先的受託研究機構 (CRO) Fortrea (Nasdaq: FTRE)（下稱「公司」）今天宣佈與 Emery Pharma 建立戰略合作關係。Emery Pharma 是一家領先的分析和生物分析受託研究機構，根據現行的《良好生產規範》(cGMP) 和《藥物非臨床研究品質管理規範》(GLP) 提供測試服務。Fortrea 與 Emery Pharma 的戰略合作將為藥物相互作用 (DDI) …
Fortrea, Emery Pharma와 협력해 FDA 기준에 맞춰 리팜핀 사용 가능한 DDI 연구 지원
GlobeNewswire
·
June 24, 2025
노스캐롤라이나주 더럼, June 24, 2025 (GLOBE NEWSWIRE) -- 글로벌 임상시험수탁기관(CRO) Fortrea(나스닥명: FTRE)(이하 “회사”)가 Emery Pharma와 전략적 협력을 발표했다. Emery Pharma는 현행우수제조관리기준(cGMP)과 우수실험실운영기준(GLP)에 맞춰 테스트 서비스를 제공하며 업계를 선도하는 분석 및 생체시료 분석 CRO로, 약물상호작용(DDI) 연구에서 선호되는 리팜핀을 대상으로 로트별 1-메틸 …